Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 3 Carcinoma, Hepatocellular 3 Neoplasms 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 NSCLC 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Leukemia, Myeloid, Chronic-Phase 1 Gynecological Cancers 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1 Adenomatous Polyposis Coli 1

Interventions

Cyclophosphamide 155 Rituximab 148 Etoposide 84 fludarabine phosphate 73 Peripheral Blood Stem Cell Transplantation 68 Mycophenolic Acid 63 Busulfan 62 Filgrastim 59 Melphalan 58 Tacrolimus 54 Whole-Body Irradiation 51 Cytarabine 46 fludarabine 45 Radiotherapy 43 Methotrexate 41 Granulocyte Colony-Stimulating Factor 41 Cyclosporine 41 Vincristine 35 Antilymphocyte Serum 35 Carmustine 33 Doxorubicin 29 Prednisone 26 Thiotepa 25 Bendamustine Hydrochloride 24 Methylprednisolone 22 Ifosfamide 22 Dexamethasone 22 thymoglobulin 21 sargramostim 20 plerixafor 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Non-Hodgkin × Pharmaceutical Preparations × Clear all

NCT00596154 2024-04-01

PCNSL

Memorial Sloan Kettering Cancer Center

Phase 2 Completed

33 enrolled 9 charts

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡